Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.
about
Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's diseaseAssociations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRIAdvances in understanding spontaneous intracerebral hemorrhage: insights from neuroimaging.White matter changes in dementia: role of impaired drainage of interstitial fluid.Cerebral amyloid angiopathy: emerging conceptsIschemic brain injury in cerebral amyloid angiopathyDiagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage.Inverse relationship between apolipoprotein A-I and cerebral white matter lesions: a cross-sectional study in middle-aged and elderly subjects.Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: A systematic critical updateOutcome markers for clinical trials in cerebral amyloid angiopathy.Antemortem MRI findings associated with microinfarcts at autopsy.Interrelationship of superficial siderosis and microbleeds in cerebral amyloid angiopathy.The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction.Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.Clinical and imaging features of mixed Alzheimer and vascular pathologies.Incidence of symptomatic hemorrhage in patients with lobar microbleeds.Dissociating Statistically-Determined Alzheimer's Disease/Vascular Dementia Neuropsychological Syndromes Using White and Gray Neuroradiological Parameters.White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy.APOE ɛ2 is associated with white matter hyperintensity volume in CADASILCortical Superficial Siderosis in Memory Clinic Patients: Further Evidence for Underlying Cerebral Amyloid Angiopathy.Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's AssociationWhite matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration.Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.Leukoaraiosis and increased cerebral susceptibility to ischemia: lack of confounding by carotid disease.Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer's disease patients and healthy subjects.Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations.Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study.Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?Cerebral amyloid angiopathy, subcortical white matter disease and dementia: literature review and study in OPTIMA.Prevalence of Brain Microbleeds in Alzheimer Disease: A Systematic Review and Meta-Analysis on the Influence of Neuroimaging Techniques.Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?Emerging concepts in sporadic cerebral amyloid angiopathy.Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept ValidationWhite matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.Intracranial Hemorrhage Risk in the Era of Antithrombotic Therapies for Ischemic Stroke.Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for TreatmentAmyloid PET imaging: applications beyond Alzheimer's disease.Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study.
P2860
Q27009411-CFAE9F74-DB30-46DC-BB8B-DE0BD81BFB84Q28533723-C7897AAE-524C-4A9A-9DDB-BE8758A6ADCCQ30825729-54EBAE8F-8385-4883-B310-9C583CF4593FQ30880445-FF2BADB6-E4A7-45EC-AF49-AD1E538F9722Q30894798-3086B98A-45F8-448F-9EF5-453783FEFADDQ30945201-D6ACB226-6B43-4B5A-A6F1-C76AE269ED91Q33581237-FB81B4C0-0CD9-4D92-A0E2-04D415AF1CF8Q33599314-13A3B2F1-5015-44F9-A557-C85222E16767Q33700069-A223E27C-4014-4463-AE2C-B0743E8EFB89Q33859442-88903FE8-4877-40D8-9A5A-13439365BF2CQ33927219-E917B24B-6FFC-4F2A-AB84-88A6A1B1BEBCQ34556470-84B9A4EE-E809-481A-9B0E-A424DC4AAC04Q34820753-52C8501B-0D32-46B8-9371-564DA7B2DC11Q34842317-1E7C6017-F9A0-4809-AC73-B77153BEA1DCQ35119419-74AC1975-54A9-48AD-AE2D-33553718A1C9Q35125123-9ACE910D-EE00-4A6A-9352-0D87D1AE0A87Q35142625-D113398C-C494-4356-8512-51ECC7B054BCQ36496101-E27F1BB6-5478-4AEB-AE81-164D983BBDCCQ36580370-865BD85E-4D2C-4241-8C05-7D52A5F63229Q36593238-9A2F139C-796E-4904-BB1D-8E7F0A553797Q36801636-D196D488-7842-43E8-8783-BE1D4BE0DBC3Q37069527-A5C461FE-8202-4817-99B7-50F28F1863C9Q37106748-592735CC-57E7-46A2-8EFF-87D6FBBB654DQ37199229-9634D6D9-51A5-4E83-BBEC-5E444870B941Q37310404-3B8AB862-D0A5-4EC0-974A-135F6F2B54A0Q37402288-5F195A34-11C1-4303-A7DC-FA94A1FBFF50Q37435248-D3D2C4EB-427E-4723-94EB-EA0615A6B9CAQ37596048-6E69C347-8BEA-4522-B676-60A67535B538Q37662448-2D1C5F9B-85DF-4BE7-9158-B4AE547185BBQ38292899-C158EBA2-7ECB-45BE-83AB-4BF8A72085C6Q38658797-DA9C78B2-B1D0-47E0-89BC-EF64BF148D3BQ38693441-3C3C6809-2395-48B6-A2E5-90E82F0C904CQ39196370-968D4EE3-2101-46B3-AEDC-8342D71CF5DCQ39639734-DDCC0168-EC42-4431-A316-519717671339Q39888008-0B05F001-759D-4DA9-A067-DF7EAEC2C528Q39962487-BC1AA22A-542E-4D8E-9599-BB10254C3DDAQ40361221-799755F9-840A-456F-B9FE-CF9BA85D39B1Q42653687-05709752-2BA4-494A-AE38-E7B12767B035Q43161462-4F26584E-59E7-4B54-AA41-D56091881FD5Q45425671-0E22E73B-6A9B-478B-A00D-8ED2494E4C0F
P2860
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cerebral amyloid angiopathy bu ...... netic resonance imaging study.
@en
Cerebral amyloid angiopathy bu ...... netic resonance imaging study.
@nl
type
label
Cerebral amyloid angiopathy bu ...... netic resonance imaging study.
@en
Cerebral amyloid angiopathy bu ...... netic resonance imaging study.
@nl
prefLabel
Cerebral amyloid angiopathy bu ...... netic resonance imaging study.
@en
Cerebral amyloid angiopathy bu ...... netic resonance imaging study.
@nl
P2093
P2860
P356
P1433
P1476
Cerebral amyloid angiopathy bu ...... gnetic resonance imaging study
@en
P2093
Alex Becker
Anand Viswanathan
Anastasia Vashkevich
Andrew Dumas
Christopher Gidicsin
Eitan Auriel
Ellis van Etten
Jeremy Carmasin
Jonathan Rosand
Keith A Johnson
P2860
P304
P356
10.1002/ANA.23830
P577
2013-02-19T00:00:00Z